Tonbo Imaging India IPO Details: Price, Dates & Financials
The Tonbo Imaging India IPO is an ongoing mainboard Bookbuilding offer (OFS only) that opened on 15 October 2026. The Tonbo Imaging India IPO will close on 19 October 2026, with an issue price of ₹700 per share. The Tonbo Imaging India IPO has a face value of ₹2 and a lot size of 21 shares. The Tonbo Imaging India IPO size aggregates up to ₹852 crore, listing on NSE & BSE on 23 October 2026. The Tonbo Imaging India IPO allotment is expected on 21 October 2026.
On the financial front, the Tonbo Imaging India IPO reported revenue of ₹37 crore for 30 Jun 2026, compared with ₹370 crore for 31 Mar 2026. The Tonbo Imaging India IPO PAT was ₹-18 crore against ₹51 crore. The Tonbo Imaging India IPO EBITDA stood at ₹-13 crore with a -36.21% margin. The Tonbo Imaging India IPO net worth as of 30 Jun 2026 was ₹539 crore.
Always verify The Tonbo Imaging India IPO details and GMP data with the official offer document before investing in the Tonbo Imaging India IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
783
783
726
Revenue
37
370
474
PAT
-18
51
73
EBITDA
-13
105
139
Net Worth
539
553
490
Reserves
527
542
489
Total Borrowing
130
116
78
Tonbo Imaging India IPO Financials FAQs
Revenue of Tonbo Imaging India (Amount in ₹ Crore) — 30 Jun 2026: 37; 31 Mar 2026: 370; 31 Mar 2025: 474. Profit after tax (PAT) — 30 Jun 2026: -18; 31 Mar 2026: 51; 31 Mar 2025: 73.
EBITDA of Tonbo Imaging India (Amount in ₹ Crore) — 30 Jun 2026: -13; 31 Mar 2026: 105; 31 Mar 2025: 139. The EBITDA margin is -36.21%.
Total assets — 30 Jun 2026: 783; 31 Mar 2026: 783; 31 Mar 2025: 726. Net worth — 30 Jun 2026: 539; 31 Mar 2026: 553; 31 Mar 2025: 490. Reserves & surplus — 30 Jun 2026: 527; 31 Mar 2026: 542; 31 Mar 2025: 489. (Amount in ₹ Crore)
Total borrowing of Tonbo Imaging India (Amount in ₹ Crore) — 30 Jun 2026: 130; 31 Mar 2026: 116; 31 Mar 2025: 78.
The financials shown for Tonbo Imaging India IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
